Acceptance Commitment Therapy for Caregivers of People with Memory Loss
Launched by UTAH STATE UNIVERSITY · Feb 17, 2023
Trial Information
Current as of July 24, 2025
Completed
Keywords
ClinConnect Summary
Literature Review An estimated 6.2 million Americans live with Alzheimer's disease or a related dementia (ADRD), and over 11 million family caregivers currently assist a person with ADRD. The combination of cognitive impairment, behavioral symptoms, and loss of a reciprocal relationship can be very challenging for caregivers. Chronic stress can affect caregivers' mental and physical health, and sometimes lead to lower quality of care for the person with ADRD. Research indicates promising pathways to support caregiver mental health through interventions that address coping skills, self-care,...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Self-identification as a family caregiver to a person with dementia or other significant memory loss
- • 2. Interest in taking part in an on-line self-guided program with multiple assessments up through 6-week follow-up
- • 3. Distressed from the care giving role, as measured by a score of 4+ on a single item "How distressed are you by caring for your family member?" (1 not at all to 10 extremely)
- • 4. Ability to read/write English
- • 5. Access to a computer/smartphone/tablet with Internet
- • 6. Caregiver does not have to live with the care recipient, as distress can arise with or without cohabitation, participants must live within the United States.
- Exclusion Criteria:
- • 1. Not caring for a family caregiver to a person with dementia or other significant memory loss
- • 2. Not interested in an on-line self-guided program with multiple assessments up through 6-week follow-up
- • 3. Responds with a score of 3 or less when asked "How distressed are you by caring for your family member?" (1 not at all to 10 extremely)
- • 4. Inability to read/write English
- • 5. Does not have reliable access to a computer/smartphone/tablet with Internet.
- • 6. Lives outside of the United States
- • 7. Younger than 18 years old
About Utah State University
Utah State University (USU) is a distinguished public research institution committed to advancing knowledge and improving health outcomes through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, USU leverages its expertise in various fields, including health sciences, engineering, and behavioral research, to conduct rigorous clinical trials. The university fosters a supportive environment for researchers and participants alike, ensuring adherence to ethical standards and regulatory requirements. USU's mission is to contribute to the betterment of community health through evidence-based findings and to translate research discoveries into practical applications that enhance the quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Logan, Utah, United States
Patients applied
Trial Officials
Audrey C Juhasz, PhD
Principal Investigator
Utah State University
Elizabeth Fauth, PhD
Study Director
Utah State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials